AIxMed, Inc.
waiting

Transforming Cytopathology Workflow

Our tools turn cytopathology from a slow and manual process into a fast and AI-powered one. Cytotechnicians and pathologists used to spend hours to manually review limited fields of view; now they can access ALL fields of view in seconds. They used to rely on qualitative descriptions; now they can instantly obtain quantitative scoring across whole samples.

Discovering clinical insights has never been easier.

cytopathlogy workflow

Benefiting Key Stakeholders

Providers

Providers

  • Minimize repetitive workload
  • Decentralization
  • Accurate diagnostics
Payers

Payers

  • Cost effective
  • Quality of care
Patients

Patients

  • Minimally invasive
  • Rapid results for improved outcomes
  • Improved outcomes

Our Platform Targets Three of the Top Cancers

Our platform is currently being used to address three of the top cancers in the United States.

Urine Cytology;(Bladder Cancer)

exfoliative

Urine Cytology

(Bladder Cancer)

  • 4th in men
  • 81,400 new cases (est. 2020)
  • 17,980 deaths (est. 2020)
Cervical Cytology;(Pap Smear)

abrasive

Cervical Cytology

(Pap Smear)

  • 4th in women
  • 13,800 new cases (est. 2020)
  • 4,290 deaths (est. 2020)
Thyroid Cytology;(Fine Needle Aspiration)

aspirational

Thyroid Cytology

(Fine Needle Aspiration)

  • 5th in women
  • 52,890 new cases (est. 2020)
  • 2,180 deaths (est. 2020)